Monday, January 23, 2017

Accelerated Examination Program - Continue?

The Federal Register (Vol. 82, No.8, Thurs., Jan. 12, 2017, pages 3758-3759) published a comment request asking input about whether the accelerated examination program should continue. The summary follows:

SUMMARY: The United States Patent and Trademark Office (USPTO) is requesting comments from its stakeholders on whether the accelerated examination program should be retained. In an August 16, 2016 notice updating the program to reflect changes in the law and examination practice, the USPTO indicated that the number of accelerated examination requests has been quite low. In particular, in each of the fiscal years 2012-2015, fewer than 250 applications were accepted into the accelerated examination program. Accordingly, the USPTO seeks feedback from its stakeholders on whether the accelerated examination program provides a sufficient benefit to the public to justify the cost of implementation.

Comment Deadline: To be ensured of consideration, written comments must be received on or before March 13, 2017. No public hearing will be held.

Addresses for Comments: Written comments should be sent by electronic mail addressed to Comments may also be submitted by mail addressed to: Mail Stop Comments--Patents,Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450, marked to the attention of Pinchus Laufer, Senior Legal Advisor, Office of Patent Legal Administration, Office of the Deputy Commissioner for Patent Examination Policy. Although comments may be submitted by mail, the USPTO prefers to receive comments via the Internet.

The comments will be available for public inspection at the Office of the Commissioner for Patents, located in Madison East, Tenth Floor, 600 Dulany Street, Alexandria, Virginia, and will be available via the USPTO Internet Web site at Because comments will be available for public inspection, information that is not desired to be made public, such as an address or phone number, should not be included in the comments.

For more information: